{{Rsnum
|rsid=6551665
|Chromosome=4
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LPHN3
|position=61873823
|Gene_s=LPHN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 44.2 | 47.8 | 8.0
| HCB | 46.0 | 40.1 | 13.9
| JPT | 35.7 | 46.4 | 17.9
| YRI | 18.6 | 44.8 | 36.6
| ASW | 24.6 | 35.1 | 40.4
| CHB | 46.0 | 40.1 | 13.9
| CHD | 47.2 | 42.6 | 10.2
| GIH | 43.6 | 39.6 | 16.8
| LWK | 22.9 | 47.7 | 29.4
| MEX | 53.4 | 36.2 | 10.3
| MKK | 32.1 | 44.2 | 23.7
| TSI | 34.3 | 57.8 | 7.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=25229170
|Title=Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}